These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5465537)

  • 1. [Experimental use of ST-613 (norethisterone 1.Omg plus mestranol 0.05mg].
    Iwata K
    Horumon To Rinsho; 1970 May; 18(5):421-2. PubMed ID: 5465537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of combined tablets of norethisterone 1.0 mg and mestranol.05 mg].
    Domon H; Washizuka N; Ishikawa M
    Horumon To Rinsho; 1969 Feb; 17(2):133-6. PubMed ID: 5815262
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contraception with two low-dosage mestranol-norethisterone combinations].
    Tenhaeff D; Feldmann HU; Rupek R
    Fortschr Med; 1972 Apr; 90(12):479-82. PubMed ID: 4641330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of norethisterone and mestrano mixture (Sophid-32) in a low dosage].
    Okada K; Yoshizaki S; Ozawa H
    Sanfujinka No Jissai; 1970 Jan; 19(1):98-102. PubMed ID: 5467334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proceedings: Adverse effects in 3 different mestranol-norethisterone administrations].
    Jacobs C; Heinen G; Umla H
    Arch Gynakol; 1973 Sep; 214(1):257-8. PubMed ID: 4801443
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
    Capra A; Trompeo P; Garetto A; Campagnoli C
    Minerva Ginecol; 1969 Aug; 21(15):967-86. PubMed ID: 5404341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of norethindrone combined with mestranol (S-3800 C) as an oral contraceptive].
    Seiga K
    Iryo; 1968 Apr; 22(4):444-52. PubMed ID: 5686370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
    Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
    Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
    [No Abstract]   [Full Text] [Related]  

  • 10. [First case of steroid jaundice caused by norethindrone and mestranol in Japan].
    Hayashi K; Okamura H; Nishikawa Y; Miura Y; Ashidaka Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1966 Dec; 18(12):1461-4. PubMed ID: 6009965
    [No Abstract]   [Full Text] [Related]  

  • 11. A new long dosage oral contraceptive, 1.0 mg. norethindrone. A preliminary study.
    Milton MD; Nelson JH
    Pac Med Surg; 1967; 75(2):127-31. PubMed ID: 6039890
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale for a new triphasic oral contraceptive.
    Pasquale SA
    Int J Fertil; 1986; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
    Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
    Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
    [No Abstract]   [Full Text] [Related]  

  • 14. Norinyl 1+80 and Ortho-Novum 1/80.
    Med Lett Drugs Ther; 1969 Apr; 11(8):35. PubMed ID: 5778361
    [No Abstract]   [Full Text] [Related]  

  • 15. A new low-dose combination oral contraceptive.
    Tyler ET
    Minn Med; 1969 Nov; 52(11):1833-6. PubMed ID: 5354091
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration.
    Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of estrogen-progesterone therapy on the pituitary-adrenal system function].
    Zárate A; Castelazo-Ayala L; Soria J
    Ginecol Obstet Mex; 1968 Oct; 24(144):407-15. PubMed ID: 5708307
    [No Abstract]   [Full Text] [Related]  

  • 18. Marginal-dose contraception in the puerperium.
    Wentz WB; Jaffe RM; Foxx RM
    Obstet Gynecol; 1966 Sep; 28(3):369-72. PubMed ID: 5950532
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

  • 20. Ortho-Novum 10/11--a new "bi-phasic" oral contraceptive.
    Med Lett Drugs Ther; 1982 Oct; 24(620):93-4. PubMed ID: 7121396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.